• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Inhaled NO in COVID-19 Acute Respiratory Distress Syndrome: Yes or No?

作者信息

Lal Amos, Gladwin Mark T, Gajic Ognjen

机构信息

Division of Pulmonary and Critical Care Medicine Mayo Clinic Rochester, Minnesota.

University of Maryland School of Medicine Baltimore, Maryland.

出版信息

Am J Respir Crit Care Med. 2023 Dec 15;208(12):1259-1261. doi: 10.1164/rccm.202310-1823ED.

DOI:10.1164/rccm.202310-1823ED
PMID:37934465
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10765394/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/246d/10765394/e8e811049ac4/rccm.202310-1823EDf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/246d/10765394/e8e811049ac4/rccm.202310-1823EDf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/246d/10765394/e8e811049ac4/rccm.202310-1823EDf1.jpg

相似文献

1
Inhaled NO in COVID-19 Acute Respiratory Distress Syndrome: Yes or No?吸入一氧化氮治疗新型冠状病毒肺炎急性呼吸窘迫综合征：是或否？
Am J Respir Crit Care Med. 2023 Dec 15;208(12):1259-1261. doi: 10.1164/rccm.202310-1823ED.
2
Effect of almitrine bismesylate and inhaled nitric oxide on oxygenation in COVID-19 acute respiratory distress syndrome.二甲磺酸阿米三嗪与吸入一氧化氮对新型冠状病毒肺炎急性呼吸窘迫综合征氧合的影响
Anaesth Crit Care Pain Med. 2020 Aug;39(4):471-472. doi: 10.1016/j.accpm.2020.05.014. Epub 2020 Jun 4.
3
Potential for personalised application of inhaled nitric oxide in COVID-19 pneumonia.吸入一氧化氮在新型冠状病毒肺炎中的个性化应用潜力。
Br J Anaesth. 2021 Feb;126(2):e72-e75. doi: 10.1016/j.bja.2020.11.006. Epub 2020 Nov 14.
4
Effects of inhaled nitric oxide in COVID-19-induced ARDS - Is it worthwhile?吸入一氧化氮治疗 COVID-19 诱导的 ARDS 的效果如何——是否值得？
Acta Anaesthesiol Scand. 2021 May;65(5):629-632. doi: 10.1111/aas.13757. Epub 2020 Dec 20.
5
Inhaled Nitric Oxide in Acute Respiratory Distress Syndrome Subsets: Rationale and Clinical Applications.吸入一氧化氮治疗急性呼吸窘迫综合征亚组患者：原理与临床应用。
J Aerosol Med Pulm Drug Deliv. 2023 Jun;36(3):112-126. doi: 10.1089/jamp.2022.0058. Epub 2023 Apr 20.
6
Inhaled Nitric Oxide vs Epoprostenol During Acute Respiratory Failure: An Observational Target Trial Emulation.吸入一氧化氮与依前列醇治疗急性呼吸衰竭：一项观察性目标模拟试验。
Chest. 2022 Dec;162(6):1287-1296. doi: 10.1016/j.chest.2022.08.001. Epub 2022 Aug 8.
7
Initiation of Inhaled Nitric Oxide by an Air Transport Team in Adult Coronavirus Disease 2019 Respiratory Failure.急性呼吸窘迫综合征成人冠状病毒病 2019 呼吸衰竭患者经空运团队吸入一氧化氮治疗的启动。
Air Med J. 2022 Jul-Aug;41(4):406-410. doi: 10.1016/j.amj.2022.03.001. Epub 2022 Mar 10.
8
Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults.吸入一氧化氮用于儿童和成人急性呼吸窘迫综合征（ARDS）的治疗
Cochrane Database Syst Rev. 2016 Jun 27;2016(6):CD002787. doi: 10.1002/14651858.CD002787.pub3.
9
A critical appraisal of a systematic review: Sokol J, Jacob SE, Bohn D: Inhaled nitric oxide for acute hypoxemic respiratory failure in children and adults. Cochrane Database Syst Rev 2003 (1): CD002787.一项系统评价的批判性评估：索科尔J、雅各布SE、博恩D：吸入一氧化氮治疗儿童和成人急性低氧性呼吸衰竭。《考科蓝系统评价数据库》2003年第1期：CD002787。
Pediatr Crit Care Med. 2005 May;6(3):340-3. doi: 10.1097/01.PCC.0000161284.96739.3A.
10
Inhaled nitric oxide minimally improves oxygenation in COVID-19 related acute respiratory distress syndrome.吸入一氧化氮对新型冠状病毒肺炎相关急性呼吸窘迫综合征患者的氧合改善作用甚微。
Br J Anaesth. 2021 Jan;126(1):e44-e46. doi: 10.1016/j.bja.2020.10.011. Epub 2020 Oct 14.

本文引用的文献

1
High-Dose Inhaled Nitric Oxide in Acute Hypoxemic Respiratory Failure Due to COVID-19: A Multicenter Phase II Trial.高剂量吸入一氧化氮治疗 COVID-19 所致低氧性呼吸衰竭：一项多中心 II 期试验。
Am J Respir Crit Care Med. 2023 Dec 15;208(12):1293-1304. doi: 10.1164/rccm.202304-0637OC.
2
Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study.评价吸入一氧化氮（iNO）治疗 COVID-19 重症危重症患者中中重度急性呼吸窘迫综合征（ARDS）的效果：一项多中心队列研究。
Crit Care. 2022 Oct 3;26(1):304. doi: 10.1186/s13054-022-04158-y.
3
Pre-hospital Aspirin Use and Patient Outcomes in COVID-19: Results from the International Viral Infection and Respiratory Illness Universal Study (VIRUS).
COVID-19 患者院前使用阿司匹林与结局的关系：国际病毒感染和呼吸道疾病普遍研究（VIRUS）的结果。
Arch Bronconeumol. 2022 Nov;58(11):746-753. doi: 10.1016/j.arbres.2022.07.017. Epub 2022 Sep 8.
4
Baricitinib in hospitalised patients with COVID-19: A meta-analysis of randomised controlled trials.巴瑞替尼用于住院COVID-19患者：随机对照试验的荟萃分析
EClinicalMedicine. 2022 Jul;49:101489. doi: 10.1016/j.eclinm.2022.101489. Epub 2022 Jun 3.
5
Therapeutic Effects of Inhaled Nitric Oxide Therapy in COVID-19 Patients.吸入一氧化氮疗法对新冠病毒肺炎患者的治疗效果
Biomedicines. 2022 Feb 3;10(2):369. doi: 10.3390/biomedicines10020369.
6
Antioxidant, anti-inflammatory and immunomodulatory roles of vitamins in COVID-19 therapy.维生素在 COVID-19 治疗中的抗氧化、抗炎和免疫调节作用。
Eur J Med Chem. 2022 Mar 15;232:114175. doi: 10.1016/j.ejmech.2022.114175. Epub 2022 Feb 4.
7
Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled Trials.托珠单抗治疗 COVID-19 住院患者：一项随机对照试验的荟萃分析。
Lung. 2021 Jun;199(3):239-248. doi: 10.1007/s00408-021-00451-9. Epub 2021 May 29.
8
Outcomes of Patients With Coronavirus Disease 2019 Receiving Organ Support Therapies: The International Viral Infection and Respiratory Illness Universal Study Registry.COVID-19 患者接受器官支持治疗的结果：国际病毒感染和呼吸道疾病通用研究登记处。
Crit Care Med. 2021 Mar 1;49(3):437-448. doi: 10.1097/CCM.0000000000004879.
9
Inhaled nitric oxide and acute kidney injury risk: a meta-analysis of randomized controlled trials.吸入一氧化氮与急性肾损伤风险：一项随机对照试验的荟萃分析。
Ren Fail. 2021 Dec;43(1):281-290. doi: 10.1080/0886022X.2021.1873805.
10
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.新型冠状病毒肺炎的肺血管内皮细胞炎症、血栓形成和血管生成。
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.